- Generic name
- Rifampicin
- Strength
- 450 mg
- Dosage form
- Capsule
- Manufactured by
- National Laboratories Ltd.
Rimpacin Capsule
About Rimpacin 450 mg Capsule
Rimpacin 450 mg capsules contain rifampicin, an antibiotic used mainly in tuberculosis treatment. It is also used to clear meningococcal bacteria from carriers. It must be taken exactly as prescribed by a doctor.
There are 18 brands of Rifampicin listed in Bangladesh. The lowest listed price is Firifam 150 mg Tablet at ৳ 1 per unit.
What is Rimpacin 450 mg Capsule?
Rimpacin 450 mg is a capsule form of rifampicin, an anti-tubercular antibiotic that works by blocking RNA transcription in bacteria. It is used for tuberculosis and to treat meningococcal carriers. Because bacteria can become resistant quickly, it is given as part of a combination regimen chosen by a doctor. Laboratory tests are usually done before treatment starts to confirm the bacteria are susceptible. The doctor decides the dose and course.
Uses of Rimpacin
Rimpacin is used in the treatment of tuberculosis and in people who carry meningococcal bacteria. For tuberculosis, it is combined with other medicines as part of a full treatment plan. It is not used alone for tuberculosis because resistance can develop. Your doctor will decide whether it is suitable for your condition and how long you need it.
How to use Rimpacin
Take Rimpacin capsules exactly as your doctor tells you. Swallow with a full glass of water. The doctor will decide the dose, timing and length of treatment. Do not skip doses or stop early, even if you feel better, as this can make the infection harder to treat. If you miss a dose, ask your doctor or pharmacist what to do. Keep all appointments for tests.
Side effects of Rimpacin
Common side effects include facial flushing and itching, nausea, vomiting, diarrhoea and stomach upset. Body fluids such as urine, sweat, saliva and tears may turn orange-red; this is expected and usually harmless. Tell your doctor if you have fever, chills, headache, dizziness, bone pain, shortness of breath, unusual tiredness, yellowing of the eyes or skin, or changes in urine output. Seek medical help for severe reactions.
Safety and precautions
Tell your doctor before starting Rimpacin if you have liver disease, kidney problems, or are allergic to rifamycins. It can affect how other medicines work, so give your doctor a full list of your medicines. In pregnancy, especially near delivery, it may cause bleeding problems in mother and baby; breastfeeding decisions need medical advice. Do not start or stop this medicine without your doctor's guidance. Your doctor will decide if monitoring tests are needed.
Frequently asked questions
Is Rimpacin safe to use during pregnancy or breastfeeding?
Rifampicin may cause bleeding problems in the mother and baby when used near the end of pregnancy. During breastfeeding, the decision to continue needs medical advice. Talk to your doctor before using Rimpacin if you are pregnant, planning pregnancy or breastfeeding; they will decide what is suitable for you.
What is Rimpacin used for and what kind of medicine is it?
Rimpacin contains rifampicin, an antibiotic used to treat tuberculosis and to clear meningococcal bacteria in carriers. It works by stopping bacteria from making RNA. It is usually given with other medicines for tuberculosis. Your doctor will decide the right combination and course for your condition.
What side effects should I watch for and when should I call the doctor?
Watch for nausea, vomiting, diarrhoea, itching, or orange-red body fluids. Call your doctor if you have fever, chills, headache, dizziness, bone pain, shortness of breath, unusual tiredness, yellowing of eyes or skin, or reduced urine. Severe reactions need urgent medical attention.
Can I stop taking Rimpacin when I feel better?
No. Stopping early or skipping doses can let bacteria survive and become resistant, making treatment harder. Always follow your doctor's instructions about how long to take it. If you have side effects or miss a dose, ask your doctor or pharmacist for advice rather than changing the plan yourself.
Indications
Pharmacology
Dosage & Administration
Tuberculosis:
- Adults: 10 mg/kg, in a single daily administration, not to exceed 600 mg/day, oral or IV
- Pediatric Patients: 10–20 mg/kg, not to exceed 600 mg/day, oral or IV
Rifampin is indicated in the treatment of all forms of tuberculosis. A three-drug regimen consisting of rifampin, isoniazid, and pyrazinamide is recommended in the initial phase of shortcourse therapy which is usually continued for 2 months. The Advisory Council for the Elimination of Tuberculosis, the American Thoracic Society, and the Centers for Disease Control and Prevention recommend that either streptomycin or ethambutol be added as a fourth drug in a regimen containing isoniazid (INH), rifampin and pyrazinamide for initial treatment of tuberculosis unless the likelihood of INH resistance is very low. The need for a fourth drug should be reassessed when the results of susceptibility testing are known. If community rates of INH resistance are currently less than 4%, an initial treatment regimen with less than four drugs may be considered.
Following the initial phase, treatment should be continued with rifampin and isoniazid for at least 4 months. Treatment should be continued for longer if the patient is still sputum or culture positive, if resistant organisms are present, or if the patient is HIV positive.
Interaction
Contraindications
Rifampin is contraindicated in patients who are also receiving atazanavir, darunavir, fosamprenavir, saquinavir, or tipranavir due to the potential of rifampin to substantially decrease plasma concentrations of these antiviral drugs, which may result in loss of antiviral efficacy and/or development of viral resistance.
Side Effects
Pregnancy & Lactation
Nursing Mothers: Because of the potential for tumorigenicity shown for rifampin in animal studies, a decision should be made whether to discontinue nursing or discontinue the drug, taking into account the importance of the drug to the mother.
Precautions & Warnings
In some cases, hyperbilirubinemia resulting from competition between rifampin and bilirubin for excretory pathways of the liver at the cell level can occur in the early days of treatment. An isolated report showing a moderate rise in bilirubin and/or transaminase level is not in itself an indication for interrupting treatment; rather, the decision should be made after repeating the tests, noting trends in the levels, and considering them in conjunction with the patient's clinical condition.
Rifampin has enzyme-inducing properties, including induction of delta amino levulinic acid synthetase. Isolated reports have associated porphyria exacerbation with rifampin administration.
Overdose Effects
Liver enlargement, possibly with tenderness, can develop within a few hours after severe overdosage; bilirubin levels may increase and jaundice may develop rapidly. Hepatic involvement may be more marked in patients with prior impairment of hepatic function. Other physical findings remain essentially normal. A direct effect upon the hematopoietic system, electrolyte levels, or acid-base balance is unlikely.
Facial or periorbital edema has also been reported in pediatric patients. Hypotension, sinus tachycardia, ventricular arrhythmias, seizures and cardiac arrest were reported in some fatal cases.
Storage Conditions
Alternative brands of Rifampicin
Other brands with the same generic name, cheapest first.
Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.